Schonfeld Strategic Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.12M Sell
7,844
-36
-0.5% -$18.9K 0.03% 566
2025
Q1
$5M Sell
7,880
-14,508
-65% -$9.2M 0.03% 463
2024
Q4
$15.9M Buy
22,388
+18,496
+475% +$13.2M 0.09% 174
2024
Q3
$4.09M Buy
3,892
+2,492
+178% +$2.62M 0.03% 511
2024
Q2
$1.47M Buy
+1,400
New +$1.47M 0.01% 922
2024
Q1
Sell
-1,500
Closed -$1.32M 2128
2023
Q4
$1.32M Sell
1,500
-2,535
-63% -$2.23M 0.01% 874
2023
Q3
$3.32M Buy
4,035
+3,127
+344% +$2.57M 0.03% 572
2023
Q2
$652K Sell
908
-2,720
-75% -$1.95M 0.01% 1095
2023
Q1
$2.98M Buy
+3,628
New +$2.98M 0.03% 588
2022
Q4
Sell
-5,380
Closed -$3.71M 2829
2022
Q3
$3.71M Sell
5,380
-8,400
-61% -$5.79M 0.03% 632
2022
Q2
$8.15M Buy
13,780
+12,519
+993% +$7.4M 0.08% 306
2022
Q1
$881K Buy
+1,261
New +$881K 0.01% 999
2021
Q4
Sell
-1,741
Closed -$1.05M 2282
2021
Q3
$1.05M Sell
1,741
-17,432
-91% -$10.6M 0.01% 861
2021
Q2
$10.7M Buy
19,173
+9,638
+101% +$5.38M 0.11% 252
2021
Q1
$4.51M Buy
9,535
+7,935
+496% +$3.75M 0.05% 424
2020
Q4
$773K Buy
+1,600
New +$773K 0.01% 858
2020
Q2
Sell
-2,454
Closed -$1.2M 1469
2020
Q1
$1.2M Buy
+2,454
New +$1.2M 0.08% 313
2019
Q3
Sell
-6,300
Closed -$1.97M 1189
2019
Q2
$1.97M Sell
6,300
-6,200
-50% -$1.94M 0.07% 292
2019
Q1
$5.13M Sell
12,500
-9,144
-42% -$3.75M 0.18% 153
2018
Q4
$8.08M Buy
21,644
+19,144
+766% +$7.15M 0.31% 77
2018
Q3
$1.01M Sell
2,500
-2,400
-49% -$970K 0.04% 428
2018
Q2
$1.69M Buy
+4,900
New +$1.69M 0.09% 300
2017
Q3
Sell
-12,500
Closed -$6.14M 729
2017
Q2
$6.14M Sell
12,500
-11,500
-48% -$5.65M 0.63% 28
2017
Q1
$9.3M Buy
24,000
+8,000
+50% +$3.1M 0.93% 11
2016
Q4
$5.87M Buy
+16,000
New +$5.87M 0.76% 19